Literature DB >> 16903202

The patient with actinic cheilosis.

Michaell A Huber1, Geza T Terezhalmy.   

Abstract

Recent research has greatly enhanced the understanding of the etiopathogenic pathways underlying squamous cell carcinoma (SCC) of the skin. The predominant etiologic agent is ultraviolet radiation. Excessive exposure to sunlight may lead to the development of sunburn, premature aging of the skin, cataracts, immune suppression, and skin cancer. Actinic keratoses represent an early clinical stage of a continuum that ultimately may progress to become SCC of the skin. Actinic cheiloses represent actinic keratoses that occur on the lip vermilion. While numerous therapeutic measures are available for managing actinic cheilosis, close follow-up, combined with strict measures to reduce future sun exposure, is mandatory. Oral health care providers are in a prime position to identify patients at risk for actinic cheiloses, educate patients on preventive measures to reduce and negate the damaging effects of sunlight, and (if necessary) manage early actinic cheiloses.

Entities:  

Mesh:

Year:  2006        PMID: 16903202

Source DB:  PubMed          Journal:  Gen Dent        ISSN: 0363-6771


  3 in total

1.  Diclofenac in hyaluronic acid gel: an alternative treatment for actinic cheilitis.

Authors:  Giana da Silveira Lima; Gabriela Ferrari da Silva; Ana Paula Neutzling Gomes; Lenita Maria Aver de Araújo; Fernanda Gonçalves Salum
Journal:  J Appl Oral Sci       Date:  2010 Sep-Oct       Impact factor: 2.698

2.  A study of actinic cheilitis treatment by two low-morbidity CO2 laser vaporization one-pass protocols.

Authors:  Flávio Francisco de Godoy Peres; Adriana Aigotti Haberbeck Brandão; Yasmin Rodarte Carvalho; Ulysses Dória Filho; Hélio Plapler
Journal:  Lasers Med Sci       Date:  2008-06-14       Impact factor: 3.161

3.  Actinic cheilitis: proposition and reproducibility of a clinical criterion.

Authors:  Nádia Antunes Poitevin; Mariana Sudati Rodrigues; Karen Loureiro Weigert; Carmen Lúcia Rodrigues Macedo; Rubem Beraldo Dos Santos
Journal:  BDJ Open       Date:  2017-08-04
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.